Intravitreal Administration of Ranibizumab for Idiopathic Choroidal Neovascularization in a Pregnant Woman

Introduction

Idiopathic choroidal neovascularization (ICNV) is a rare form of choroidal neovascularization (CNV) affecting patients of working age (age ≤ 50 years) and having a significant impact on visual acuity (VA) and quality of life [1]. The occurrence of ICNV in pregnancy is very rare and has been reported in the literature only twice [2] [3]. Treatment of ICNV with ranibizumab and bevacizumab has been reported in small case series [3] [4] [5].

We report a case of subfoveal ICNV and its treatment with intravitreal ranibizumab in a healthy, young woman during the third trimester of pregnancy.

• References

• 1 Lindblom B, Andersson T. The prognosis of idiopathic choroidal neovascularization in persons younger than 50 years of age. Ophthalmology 1998; 105: 1816-1820
• 2 Rhee P, Dev S, Mieler WF. The development of choroidal neovascularization in pregnancy. Retina 1999; 19: 520-524
• 3 Anastasilakis K, Symeonidis C, Kaprinis K et al. Peripapillary neovascular membrane in a young pregnant woman and prompt response to ranibizumab injections following uneventful delivery. Case Report. Ophthalmol 2011; 2: 129-133
• 4 Mandal S, Garg S, Venkatesh P et al. Intravitreal bevacizumab for subfoveal idiopathic choroidal neovascularization. Arch Ophthalmol 2007; 125: 1487-1492
• 5 Chan WM, Lai TY, Liu DT et al. Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol 2007; 143: 977-983
• 6 Sim DA, Sheth HG, Kaines A et al. Punctate inner choroidopathy-associated choroidal neovascular membranes during pregnancy. Eye 2008; 22: 725-727
• 7 Vuorela P, Hatva E, Lymboussaki A et al. Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod 1997; 56: 489-494
• 8 US Food and Drug Administration. LUCENTIS^TM (ranibizumab injection). 2006 http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/125156lbl.pdf (accessed 5^th November 2011).
• 9 Friberg TR. Ranibizumab-pegaptanib therapy for idiopathic choroidal neovascularization: report of a case. Semin Ophthalmol 2007; 22: 137-139